Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative-effect of Accounting Change Adopted [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative-effect of Accounting Change Adopted [Member]
Accumulated Other Comprehensive Income [Member]
Beginning balance at Dec. 31, 2020 $ 88,210   $ 32 $ 368,477 $ (280,365)   $ 66
Beginning balance, shares at Dec. 31, 2020     31,799,354        
Common stock issued under employee stock plans, net 4,254   $ 1 4,253      
Common stock issued under employee stock plans, net, shares     608,886        
Common stock issued for services 119     119      
Common stock issued for services, shares     15,828        
Stock-based compensation expense 21,491     21,491      
Exercise of warrants 2,279   $ 2,279 2,279      
Exercise of warrants, shares     252,218        
Net loss (30,567)       (30,567)    
Other comprehensive gain (loss) 7           7
Ending balance at Mar. 31, 2021 85,793   $ 33 396,619 (310,932)   73
Ending balance, shares at Mar. 31, 2021     32,676,286        
Beginning balance at Dec. 31, 2020 88,210   $ 32 368,477 (280,365)   66
Beginning balance, shares at Dec. 31, 2020     31,799,354        
Net loss (70,593)            
Ending balance at Dec. 31, 2021 80,579 $ (677) $ 35 431,606 (350,958) $ (677) (104)
Ending balance, shares at Dec. 31, 2021     34,972,256        
Common stock issued under employee stock plans, net 570   $ 1 569      
Common stock issued under employee stock plans, net, shares     1,073,543        
Common stock withheld for employee taxes (9,437)     (9,437)      
Common stock withheld for employee taxes, shares     (457,840)        
Common stock issued for acquisitions 1,929     1,929      
Common stock issued for acquisitions, shares     116,550        
Common stock issued as part of contingent consideration 6,440     6,440      
Common stock issued as part of contingent consideration, shares     352,330        
Stock-based compensation expense 4,847     4,847      
Net loss (28,441)       (28,441)    
Other comprehensive gain (loss) 190           190
Ending balance at Mar. 31, 2022 $ 56,000   $ 36 $ 435,954 $ (380,076)   $ 86
Ending balance, shares at Mar. 31, 2022     36,056,839